BUSINESS● LOWSep 18 · Sep 18, 2026, 3:28 PM
Cue Biopharma is a new Buy at B. Riley on valuation
Seeking Alpha Tech · global
Cue Biopharma has received a new 'Buy' rating from B. Riley, based on its valuation. This indicates a positive assessment of the company's financial prospects.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS41m agoBrixmor Property raises dividend by 7.3% to $0.33 a shareSeeking Alpha TechBUSINESS47m agoKansas City Life Insurance declares $0.18 dividendSeeking Alpha Tech